SEARCH

SEARCH BY CITATION

References

  • Aguzzi A. (2003) Prions and the immune system: a journey through gut, spleen, and nerves. Adv. Immunol. 81, 123171.
  • Aguzzi A. (2004) Understanding the diversity of prions. Nat. Cell Biol. 6, 290292.
  • Aguzzi A. and Hardt W. D. (2003) Dangerous liaisons between a microbe and the prion protein. J. Exp. Med. 198, 14.
  • Aguzzi A. and Weissmann C. (1996) Spongiform encephalopathies: a suspicious signature. Nature 383, 666667.
  • Alper T., Haig D. A. and Clarke M. C. (1966) The exceptionally small size of the scrapie agent. Biochem. Biophys. Res. Commun. 22, 278284.
  • Alper T., Cramp W. A., Haig D. A. and Clarke M. C. (1967) Does the agent of scrapie replicate without nucleic acid? Nature 214, 764766.
  • De Andres D., Klein D., Watt N. J., Berriatua E., Torsteinsdottir S., Blacklaws B. A. and Harkiss G. D. (2005) Diagnostic tests for small ruminant lentiviruses. Vet. Microbiol. 107, 4962.
  • Asante E. A., Linehan J. M., Desbruslais M et al. (2002) BSE prions propagate as either variant CJD-like or sporadic CJD-like prion strains in transgenic mice expressing human prion protein. EMBO J. 21, 63586366.
  • Basler K., Oesch B., Scott M., Westaway D., Walchli M., Groth D. F., McKinley M. P., Prusiner S. B. and Weissmann C. (1986) Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene. Cell 46, 417428.
  • Blättler T., Brandner S., Raeber A. J., Klein M. A., Voigtländer T., Weissmann C. and Aguzzi A. (1997) PrP-expressing tissue required for transfer of scrapie infectivity from spleen to brain. Nature 389, 6973.
  • Bons N., Mestre-Frances N., Belli P., Cathala F., Gajdusek D. C. and Brown P. (1999) Natural and experimental oral infection of nonhuman primates by bovine spongiform encephalopathy agents. Proc. Natl. Acad. Sci. U.S.A. 96, 40464051.
  • Brandner S., Isenmann S., Raeber A., Fischer M., Sailer A., Kobayashi Y., Marino S., Weissmann C. and Aguzzi A. (1996a) Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature 379, 339343.
  • Brandner S., Raeber A., Sailer A., Blattler T., Fischer M., Weissmann C. and Aguzzi A. (1996b) Normal host prion protein (PrPC) is required for scrapie spread within the central nervous system. Proc. Natl. Acad. Sci. U.S.A. 93, 13 14813 151.
  • Brown P., Preece M. A. and Will R. G. (1992) ‘Friendly fire’ in medicine: hormones, homografts, and Creutzfeldt-Jakob disease. Lancet 340, 2427.
  • Brown D. R., Schmidt B. and Kretzschmar H. A. (1996) Role of microglia and host protein in neurotoxicity of a prion protein fragment. Nature 380, 345347.
  • Bruce M. E., Will R. G., Ironside J. W. et al. (1997) Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agent. Nature 389, 498501.
  • Büeler H. R., Fischer M., Lang Y., Bluethmann H., Lipp H. P., DeArmond S. J., Prusiner S. B., Aguet M. and Weissmann C. (1992) Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 356, 577582.
  • Büeler H. R., Aguzzi A., Sailer A., Greiner R. A., Autenried P., Aguet M. and Weissmann C. (1993) Mice devoid of PrP are resistant to scrapie. Cell 73, 13391347.
  • Bueler H., Raeber A., Sailer A., Fischer M., Aguzzi A. and Weissmann C. (1994) High prion and PrPSc levels but delayed onset of disease in scrapie-inoculated mice heterozygous for a disrupted PrP gene. Mol. Med. 1, 1930.
  • Carrozza M. L., Mazzei M., Bandecchi P., Arispici M. and Tolari F. (2003) In situ PCR-associated immunohistochemistry identifies cell types harbouring the Maedi-Visna virus genome in tissue sections of sheep infected naturally. J. Virol. Methods 107, 121127.
  • Cashman N. R., Loertscher R., Nalbantoglu J., Shaw I., Kascsak R. J., Bolton D. C. and Bendheim P. E. (1990) Cellular isoform of the scrapie agent protein participates in lymphocyte activation. Cell 61, 185192.
  • Castilla J., Saa P., Hetz C. and Soto C. (2005a) In vitro generation of infectious scrapie prions. Cell 121, 195206.
  • Castilla J., Saa P. and Soto C. (2005b) Detection of prions in blood. Nat. Med. 11, 982985.
  • Caughey B. and Chesebro B. (2001) Transmissible spongiform encephalopathies and prion protein interconversions. Adv. Virus Res. 56, 277311.
  • Chandler R. L. (1961) Encephalopathy in mice produced by inoculation with scrapie brain material. Lancet i, 13781379.
  • Chesebro B., Race R., Wehrly K., Nishio J., Bloom M., Lechner D., Bergstrom S., Robbins K., Mayer L. and Keith J. M. (1985) Identification of scrapie prion protein-specific mRNA in scrapie-infected and uninfected brain. Nature 315, 331333.
  • Chiesa R., Piccardo P., Quaglio E., Drisaldi B., Si-Hoe S. L., Takao M., Ghetti B. and Harris D. A. (2003) Molecular distinction between pathogenic and infectious properties of the prion protein. J. Virol. 77, 76117622.
  • Collinge J., Whittington M. A., Sidle K. C., Smith C. J., Palmer M. S., Clarke A. R. and Jefferys J. G. (1994) Prion protein is necessary for normal synaptic function. Nature 370, 295297.
  • Collinge J., Beck J., Campbell T., Estibeiro K. and Will R. G. (1996a) Prion protein gene analysis in new variant cases of Creutzfeldt-Jakob disease. Lancet 348, 56.
  • Collinge J., Sidle K. C., Meads J., Ironside J. and Hill A. F. (1996b) Molecular analysis of prion strain variation and the aetiology of ‘new variant’ CJD. Nature 383, 685690.
  • Creutzfeldt H. G. (1920) Über eine eigenartige herdförmige Erkrankung des Zentralnervensystems. Z. Gesamte Neurol. Psychiatr. 57, 119.
  • Cuille J. and Chelle P. L. (1939) Experimental transmission of trembling to the goat. C. R. Seances Acad. Sci. 208, 10581160.
  • Deleault N. R., Lucassen R. W. and Supattapone S. (2003) RNA molecules stimulate prion protein conversion. Nature 425, 717720.
  • Dickinson A. G., Meikle V. M. and Fraser H. (1968) Identification of a gene which controls the incubation period of some strains of scrapie agent in mice. J. Comp. Pathol. 78, 293299.
  • Drisaldi B., Stewart R. S., Adles C., Stewart L. R., Quaglio E., Biasini E., Fioriti L., Chiesa R. and Harris D. A. (2003) Mutant PrP is delayed in its exit from the endoplasmic reticulum, but neither wild-type nor mutant PrP undergoes retrotranslocation prior to proteasomal degradation.J. Biol. Chem. 278, 21 73221 743.
  • Duffy P., Wolf J., Collins G., DeVoe A. G., Streeten B. and Cowen D. (1974) Possible person-to-person transmission of Creutzfeldt-Jakob disease. N. Engl. J. Med. 290, 692693.
  • Enari M., Flechsig E. and Weissmann C. (2001) Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody. Proc. Natl. Acad. Sci. U.S.A. 98, 92959299.
  • Felten D. L. and Felten S. Y. (1988) Sympathetic noradrenergic innervation of immune organs. Brain Behav. Immun. 2, 293300.
  • Fischer M. B., Roeckl C., Parizek P., Schwarz H. P. and Aguzzi A. (2000) Binding of disease-associated prion protein to plasminogen. Nature 408, 479483.
  • Forloni G., Angeretti N., Chiesa R., Monzani E., Salmona M., Bugiani O. and Tagliavini F. (1993) Neurotoxicity of a prion protein fragment. Nature 362, 543546.
  • Foster J. D., Bruce M., McConnell I., Chree A. and Fraser H. (1996) Detection of BSE infectivity in brain and spleen of experimentally infected sheep. Vet. Rec. 138, 546548.
  • Frigg R., Klein M. A., Hegyi I., Zinkernagel R. M. and Aguzzi A. (1999) Scrapie pathogenesis in subclinically infected B-cell-deficient mice. J. Virol. 73, 95849588.
  • Gabizon R., McKinley M. P., Groth D. and Prusiner S. B. (1988) Immunoaffinity purification and neutralization of scrapie prion infectivity. Proc. Natl. Acad. Sci. U.S.A. 85, 66176621.
  • Gajdusek D. C. (1977) Unconventional viruses and the origin and disappearance of kuru. Science 197, 943960.
  • Gajdusek D. C. and Zigas V. (1957) Degenerative disease of the central nervous system in New Guinea – the endemic occurrence of ‘kuru’ in the native population. N. Engl. J. Med. 257, 974978.
  • Gajdusek D. C., Gibbs C. J. and Alpers M. (1966) Experimental transmission of a Kuru–like syndrome to chimpanzees. Nature 209, 794796.
  • Gajdusek D. C., Gibbs C. J. Jr and Alpers M. (1967) Transmission and passage of experimenal ‘kuru’ to chimpanzees. Science 155, 212214.
  • Gibbs C. J. Jr, Gajdusek D. C., Asher D. M., Alpers M. P., Beck E., Daniel P. M. and Matthews W. B. (1968) Creutzfeldt-Jakob disease (spongiform encephalopathy): transmission to the chimpanzee. Science 161, 388389.
  • Glatzel M., Heppner F. L., Albers K. M. and Aguzzi A. (2001) Sympathetic innervation of lymphoreticular organs is rate limiting for prion neuroinvasion. Neuron 31, 2534.
  • Glatzel M., Rogivue C., Ghani A., Streffer J. R., Amsler L. and Aguzzi A. (2002) Incidence of Creutzfeldt-Jakob disease in Switzerland. Lancet 360, 139141.
  • Glatzel M., Abela E., Maissen M. and Aguzzi A. (2003a) Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease. N. Engl. J. Med. 349, 18121820.
  • Glatzel M., Ott P. M., Lindner T. et al. (2003b) Human prion diseases: epidemiology and integrated risk assessment. Lancet Neurol. 2, 757763.
  • Goldfarb L. G., Brown P., McCombie W. R., Goldgaber D., Swergold G. D., Wills P. R., Cervenakova L., Baron H., Gibbs C. J. Jr and Gajdusek D. C. (1991) Transmissible familial Creutzfeldt-Jakob disease associated with five, seven, and eight extra octapeptide coding repeats in the PRNP gene. Proc. Natl. Acad. Sci. U.S.A. 88, 10 92610 930.
  • Griffith J. S. (1967) Self-replication and scrapie. Nature 215, 10431044.
  • Hadlow W. J. (1959) Scrapie and kuru. Lancet ii, 289290.
  • Haik S., Faucheux B. A., Sazdovitch V., Privat N., Kemeny J. L., Perret-Liaudet A. and Hauw J. J. (2003) The sympathetic nervous system is involved in variant Creutzfeldt-Jakob disease. Nat. Med. 9, 11211122.
  • Hegde R. S., Mastrianni J. A., Scott M. R., DeFea K. A., Tremblay P., Torchia M., DeArmond S. J., Prusiner S. B. and Lingappa V. R. (1998) A transmembrane form of the prion protein in neurodegenerative disease. Science 279, 827834.
  • Hegde R. S., Tremblay P., Groth D., DeArmond S. J., Prusiner S. B. and Lingappa V. R. (1999) Transmissible and genetic prion diseases share a common pathway of neurodegeneration. Nature 402, 822826.
  • Heikenwalder M., Polymenidou M., Junt T., Sigurdson C., Wagner H., Akira S., Zinkernagel R. and Aguzzi A. (2004) Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration. Nat. Med. 10, 187192.
  • Heikenwalder M., Zeller N., Seeger H., Prinz M., Klohn P. C., Schwarz P., Ruddle N. H., Weissmann C. and Aguzzi A. (2005) Chronic lymphocytic inflammation specifies the organ tropism of prions. Science 307, 11071110.
  • Heinen E., Bosseloir A. and Bouzahzah F. (1995) Follicular dendritic cells: origin and function. Curr. Top. Microbiol. Immunol. 201, 1547.
  • Heller U., Winklhofer K. F., Heske J., Reintjes A. and Tatzelt J. (2003) Post-translational import of the prion protein into the endoplasmic reticulum interferes with cell viability: a critical role for the putative transmembrane domain. J. Biol. Chem. 278, 36 13936 147.
  • Heppner F. L., Musahl C., Arrighi I., Klein M. A., Rulicke T., Oesch B., Zinkernagel R. M., Kalinke U. and Aguzzi A. (2001) Prevention of scrapie pathogenesis by transgenic expression of anti-prion protein antibodies. Science 294, 178182.
  • Hill A. F., Butterworth R. J., Joiner S. et al. (1999) Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet 353, 183189.
  • Hill A. F., Desbruslais M., Joiner S., Sidle K. C., Gowland I., Collinge J., Doey L. J. and Lantos P. (1997) The same prion strain causes vCJD and BSE[letter]. Nature 389, 448450.
  • Hilton D. A., Ghani A. C., Conyers L., Edwards P., McCardle L., Ritchie D., Penney M., Hegazy D. and Ironside J. W. (2004) Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J. Pathol. 203, 733739.
  • Horiuchi M. and Caughey B. (1999) Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease-resistant state. EMBO J. 18, 31933203.
  • Houston F., Foster J. D., Chong A., Hunter N. and Bostock C. J. (2000) Transmission of BSE by blood transfusion in sheep. Lancet 356, 9991000.
  • Hsiao K., Baker H. F., Crow T. J., Poulter M., Owen F., Terwilliger J. D., Westaway D., Ott J. and Prusiner S. B. (1989) Linkage of a prion protein missense variant to Gerstmann–Straussler syndrome. Nature 338, 342345.
  • Hsich G., Kinney K., Gibbs C. J., Lee K. H. and Harrington M. G. (1996) The 14–3−3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N. Engl. J. Med. 335, 924930.
  • Jackson G. S., Beck J. A., Navarrete C., Brown J., Sutton P. M., Contreras M. and Collinge J. (2001) HLA-DQ7 antigen and resistance to variant CJD. Nature 414, 269270.
  • Jakob A. (1921) Über eigenartige Erkrankungen des Zentralnervensystems mit bemerkenswertem anatomischem. Befunde. (Spastische Pseudosklerose-Encephalomyelopathie mit disseminierten Degenerationsherden). Z. Gesamte Neurol. Psychiatr. 64, 147228.
  • Kaeser P. S., Klein M. A., Schwarz P. and Aguzzi A. (2001) Efficient lymphoreticular prion propagation requires PrP(c) in stromal and hematopoietic cells. J. Virol. 75, 70977106.
  • King C. Y. and Diaz-Avalos R. (2004) Protein-only transmission of three yeast prion strains. Nature 428, 319323.
  • Kitamoto T., Muramoto T., Mohri S., Doh-Ura K. and Tateishi J. (1991) Abnormal isoform of prion protein accumulates in follicular dendritic cells in mice with Creutzfeldt-Jakob disease. J. Virol. 65, 62926295.
  • Klein M. A., Frigg R., Flechsig E., Raeber A. J., Kalinke U., Bluethmann H., Bootz F., Suter M., Zinkernagel R. M. and Aguzzi A. (1997) A crucial role for B cells in neuroinvasive scrapie. Nature 390, 687690.
  • Klein M. A., Frigg R., Raeber A. J., Flechsig E., Hegyi I., Zinkernagel R. M., Weissmann C. and Aguzzi A. (1998) PrP expression in B lymphocytes is not required for prion neuroinvasion. Nat. Med. 4, 14291433.
  • Klein M. A., Kaeser P. S., Schwarz P. et al. (2001) Complement facilitates early prion pathogenesis. Nat. Med. 7, 488492.
  • Kocisko D. A., Come J. H., Priola S. A., Chesebro B., Raymond G. J., Lansbury P. T. and Caughey B. (1994) Cell-free formation of protease-resistant prion protein. Nature 370, 471474.
  • Korth C., Stierli B., Streit P. et al. (1997) Prion (PrPSc)-specific epitope defined by a monoclonal antibody. Nature 390, 7477.
  • Kunz B., Sandmeier E. and Christen P. (1999) Neurotoxicity of prion peptide 106–126 not confirmed. FEBS Lett. 458, 6568.
  • Ladogana A. et al. (2005) Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia and Canada. Neurology. 64, 15861591.
  • Legname G., Baskakov I. V., Nguyen H. O., Riesner D., Cohen F. E., DeArmond S. J. and Prusiner S. B. (2004) Synthetic mammalian prions. Science 305, 673676.
  • Legname G., Nguyen H. O., Baskakov I. V., Cohen F. E., Dearmond S. J. and Prusiner S. B. (2005) Strain-specified characteristics of mouse synthetic prions. Proc. Natl. Acad. Sci. U.S.A. 102, 21682173.
  • Lerondelle C. and Ouzrout R. (1990) Expression of maedi-visna virus in mammary secretions of a seropositive ewe. Dev. Biol. Stand. 72, 223227.
  • Ligios C., Sigurdson C. J., Santucciu C., Carcassola G., Manco G., Basagni M., Maestrale C., Cancedda M. G., Madau L. and Aguzzi A. (2005) PrPSc in mammary glands of sheep affected by scrapie and mastitis. Nat. Med. 11, 11371138.
  • Lloyd S. E., Onwuazor O. N., Beck J. A., Mallinson G., Farrall M., Targonski P., Collinge J. and Fisher E. M. (2001) Identification of multiple quantitative trait loci linked to prion disease incubation period in mice. Proc. Natl. Acad. Sci. U.S.A. 98, 62796283.
  • Ma J. and Lindquist S. (2002) Conversion of PrP to a self-perpetuating PrPSc-like conformation in the cytosol. Science 298, 17851788.
  • Ma J., Wollmann R. and Lindquist S. (2002) Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol. Science 298, 17811785.
  • Mabbott N. A., Bruce M. E., Botto M., Walport M. J. and Pepys M. B. (2001) Temporary depletion of complement component C3 or genetic deficiency of C1q significantly delays onset of scrapie. Nat. Med. 7, 485487.
  • Mabbott N. A., McGovern G., Jeffrey M. and Bruce M. E. (2002) Temporary blockade of the tumor necrosis factor receptor signaling pathway impedes the spread of scrapie to the brain. J. Virol. 76, 51315139.
  • Mabbott N. A., Young J., McConnell I. and Bruce M. E. (2003) Follicular dendritic cell dedifferentiation by treatment with an inhibitor of the lymphotoxin pathway dramatically reduces scrapie susceptibility. J. Virol. 77, 68456854.
  • Manolakou K., Beaton J., McConnell I., Farquar C., Manson J., Hastie N. D., Bruce M. and Jackson I. J. (2001) Genetic and environmental factors modify bovine spongiform encephalopathy incubation period in mice. Proc. Natl. Acad. Sci. U.S.A. 98, 74027407.
  • Manson J. C., Clarke A. R., Hooper M. L., Aitchison L., McConnell I. and Hope J. (1994) 129/Ola mice carrying a null mutation in PrP that abolishes mRNA production are developmentally normal. Mol. Neurobiol. 8, 121127.
  • McKinley M. P., Bolton D. C. and Prusiner S. B. (1983) A protease-resistant protein is a structural component of the scrapie prion. Cell 35, 5762.
  • Mead S., Stumpf M. P., Whitfield J. et al. (2003) Balancing selection at the prion protein gene consistent with prehistoric kurulike epidemics. Science 300, 640643.
  • Meier P., Genoud N., Prinz M., Maissen M., Rulicke T., Zurbriggen A., Raeber A. J. and Aguzzi A. (2003) Soluble dimeric prion protein binds PrP (Sc) in vivo and antagonizes prion disease. Cell 113, 4960.
  • Montrasio F., Frigg R., Glatzel M., Klein M. A., Mackay F., Aguzzi A. and Weissmann C. (2000) Impaired prion replication in spleens of mice lacking functional follicular dendritic cells. Science 288, 12571259.
  • Moore R. C., Hope J., McBride P. A., McConnell I., Selfridge J., Melton D. W. and Manson J. C. (1998) Mice with gene targetted prion protein alterations show that Prnp, Sinc and Prni are congruent. Nat. Genet 18, 118125.
  • Moore R. C., Lee I. Y., Silverman G. L. et al. (1999) Ataxia in prion protein (PrP)-deficient mice is associated with upregulation of the novel PrP-like protein doppel[In Process Citation]. J. Mol Biol. 292, 797817.
  • Moreno C. R., Lantier F., Lantier I., Sarradin P. and Elsen J. M. (2003) Detection of new quantitative trait loci for susceptibility to transmissible spongiform encephalopathies in mice. Genetics 165, 20852091.
  • Oesch B., Westaway D., Walchli M. et al. (1985) A cellular gene encodes scrapie PrP 27–30 protein. Cell 40, 735746.
  • Pan K. M., Baldwin M., Nguyen J. et al. (1993) Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc. Natl. Acad. Sci. U.S.A. 90, 10 96210 966.
  • Paramithiotis E., Pinard M., Lawton T. et al. (2003) A prion protein epitope selective for the pathologically misfolded conformation. Nat. Med. 9, 893899.
  • Parchi P., Castellani R., Capellari S. et al. (1996) Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob Disease. Ann. Neurol. 39, 767778.
  • Pattison I. H. and Millson G. C. (1961) Scrapie produced experimentally in goats with special reference to the clinical syndrome. J. Comp. Pathol. 71, 101108.
  • Peden A. H., Head M. W., Ritchie D. L., Bell J. E. and Ironside J. W. (2004) Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 364, 527529.
  • Pepin M., Vitu C., Russo P., Mornex J. F. and Peterhans E. (1998) Maedi-visna virus infection in sheep: a review. Vet. Res. 29, 341367.
  • Pepys M. B., Bybee A., Booth D. R., Bishop M. T., Will R. G., Little A. M., Prokupek B. and Madrigal J. A. (2003) MHC typing in variant Creutzfeldt-Jakob disease. Lancet 361, 487489.
  • Peretz D., Williamson R. A., Kaneko K. et al. (2001) Antibodies inhibit prion propagation and clear cell cultures of prion infectivity. Nature 412, 739743.
  • Perrier V., Solassol J., Crozet C., Frobert Y., Mourton-Gilles C., Grassi J. and Lehmann S. (2004) Anti-PrP antibodies block PrPSc replication in prion-infected cell cultures by accelerating PrPC degradation. J. Neurochem. 89, 454463.
  • Peterhans E., Greenland T., Badiola J. et al. (2004) Routes of transmission and consequences of small ruminant lentiviruses (SRLVs) infection and eradication schemes. Vet. Res. 35, 257274.
  • Polymenidou M., Heppner F. L., Pellicioli E. C., Urich E., Miele G., Braun N., Wopfner F., Schaetzl H., Becher B. and Aguzzi A. (2004) Humoral immune response to native eukaryotic prion protein correlates with anti-prion protection. Proc. Natl. Acad. Sci. U.S.A. 101, 14 67014 676.
  • Polymenidou M., Stoeck K., Glatzel M., Vey M., Bellon A. and Aguzzi A. (2005) Coexistence of multiple PrPSc types in individuals with Creutzfeldt-Jakob disease. Lancet Neurol. 4, 805814.
  • Preziuso S., Renzoni G., Allen T. E., Taccini E., Rossi G., DeMartini J. C. and Braca G. (2004) Colostral transmission of maedi visna virus: sites of viral entry in lambs born from experimentally infected ewes. Vet. Microbiol. 104, 157164.
  • Prinz M., Heikenwalder M., Schwarz P., Takeda K., Akira S. and Aguzzi A. (2003a) Prion pathogenesis in the absence of Toll-like receptor signalling. EMBO Rep 4, 195199.
  • Prinz M., Huber G., Macpherson A. J., Heppner F. L., Glatzel M., Eugster H. P., Wagner N. and Aguzzi A. (2003b) Oral prion infection requires normal numbers of Peyer's patches but not of enteric lymphocytes. Am. J. Pathol 162, 11031111.
  • Prinz M., Heikenwalder M., Junt T., Schwarz P., Glatzel M., Heppner F. L., Fu Y. X., Lipp M. and Aguzzi A. (2003c) Positioning of follicular dendritic cells within the spleen controls prion neuroinvasion. Nature 425, 957962.
  • Prusiner S. B. (1982) Novel proteinaceous infectious particles cause scrapie. Science 216, 136144.
  • Prusiner S. B. (1989) Scrapie prions. Annu. Rev. Microbiol. 43, 345374.
  • Prusiner S. B., Groth D. F., Cochran S. P., Masiarz F. R., McKinley M. P. and Martinez H. M. (1980) Molecular properties, partial purification, and assay by incubation period measurements of the hamster scrapie agent. Biochemistry 19, 48834891.
  • Prusiner S. B., Groth D., Serban A., Koehler R., Foster D., Torchia M., Burton D., Yang S. L. and DeArmond S. J. (1993) Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies. Proc. Natl. Acad. Sci. U.S.A. 90, 10 60810 612.
  • Riek R., Hornemann S., Wider G., Billeter M., Glockshuber R. and Wuthrich K. (1996) NMR structure of the mouse prion protein domain PrP(121–231). Nature 382, 180182.
  • Rossetti A. O., Bogousslavsky J., Glatzel M. and Aguzzi A. (2004) Mimicry of variant Creutzfeldt-Jakob disease by sporadic Creutzfeldt-Jakob disease: importance of the pulvinar sign. Arch. Neurol. 61, 445446.
  • Roucou X., Guo Q., Zhang Y., Goodyer C. G. and LeBlanc A. C. (2003) Cytosolic prion protein is not toxic and protects against Bax-mediated cell death in human primary neurons. J. Biol. Chem. 278, 40 87740 881.
  • Saborio G. P., Permanne B. and Soto C. (2001) Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 411, 810813.
  • Safar J., Wille H., Itri V., Groth D., Serban H., Torchia M., Cohen F. E. and Prusiner S. B. (1998) Eight prion strains have PrP(Sc) molecules with different conformations. Nat. Med. 4, 11571165.
  • Sailer A., Büeler H., Fischer M., Aguzzi A. and Weissmann C. (1994) No propagation of prions in mice devoid of PrP. Cell 77, 967968.
  • Schwartz M. (2003) How the Cows Turned Mad. Berkeley, CA: University of California Press.
  • Scott M., Foster D., Mirenda C. et al. (1989) Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques. Cell 59, 847857.
  • Seeger H., Heikenwalder M., Zeller N., Kranich J., Schwarz P., Gaspert A., Seifert B., Miele G. and Aguzzi A. (2005) Coincident scrapie infection and nephritis lead to urinary prion excretion. Science 310, 324326.
  • Sethi S., Lipford G., Wagner H. and Kretzschmar H. (2002) Postexposure prophylaxis against prion disease with a stimulator of innate immunity. Lancet 360, 229230.
  • Shibuya S., Higuchi J., Shin R. W., Tateishi J. and Kitamoto T. (1998) Codon 219 Lys allele of PRNP is not found in sporadic Creutzfeldt-Jakob disease. Ann. Neurol. 43, 826828.
  • Solforosi L., Criado J. R., McGavern D. B. et al. (2004) Cross-linking cellular prion protein triggers neuronal apoptosis in vivo. Science 303, 514516.
  • Souan L., Tal Y., Felling Y., Cohen I. R., Taraboulos A. and Mor F. (2001) Modulation of proteinase-K resistant prion protein by prion peptide immunization. Eur J. Immunol. 31, 23382346.
  • Stephenson D. A., Chiotti K., Ebeling C., Groth D., DeArmond S. J., Prusiner S. B. and Carlson G. A. (2000) Quantitative trait loci affecting prion incubation time in mice. Genomics 69, 4753.
  • Tanaka M., Chien P., Naber N., Cooke R. and Weissman J. S. (2004) Conformational variations in an infectious protein determine prion strain differences. Nature 428, 323328.
  • Tateishi J. and Kitamoto T. (1995) Inherited prion diseases and transmission to rodents. Brain Pathol. 5, 5359.
  • Tobler I., Gaus S. E., Deboer T., Achermann P., Fischer M., Rülicke T., Moser M., Oesch B., McBride P. A. and Manson J. C. (1996) Altered circadian activity rhythms and sleep in mice devoid of prion protein. Nature 380, 639642.
  • Valleron A. J., Boelle P. Y., Will R. and Cesbron J. Y. (2001) Estimation of epidemic size and incubation time based on age characteristics of vCJD in the United Kingdom. Science 294, 17261728.
  • Watarai M., Kim S., Erdenebaatar J., Makino S., Horiuchi M., Shirahata T., Sakaguchi S. and Katamine S. (2003) Cellular prion protein promotes Brucella infection into macrophages. J. Exp. Med. 198, 517.
  • Weissmann C. (1991) Spongiform encephalopathies. The prion's progress. Nature 349, 569571.
  • Weissmann C. and Flechsig E. (2003) PrP knock-out and PrP transgenic mice in prion research. Br. Med. Bull. 66, 4360.
  • Wells G. A., Scott A. C., Johnson C. T., Gunning R. F., Hancock R. D., Jeffrey M., Dawson M. and Bradley R. (1987) A novel progressive spongiform encephalopathy in cattle. Vet. Rec. 121, 419420.
  • Westaway D., Goodman P. A., Mirenda C. A., McKinley M. P., Carlson G. A. and Prusiner S. B. (1987) Distinct prion proteins in short and long scrapie incubation period mice. Cell 51, 651662.
  • White A. R., Enever P., Tayebi M., Mushens R., Linehan J., Brandner S., Anstee D., Collinge J. and Hawke S. (2003) Monoclonal antibodies inhibit prion replication and delay the development of prion disease. Nature 422, 8083.
  • Wickner R. B. (1994) [URE3] as an altered URE2 protein: evidence for a prion analog in Saccharomyces cerevisiae. Science 264, 566569.
  • Will R. G., Ironside J. W., Zeidler M., Cousens S. N., Estibeiro K., Alperovitch A., Poser S., Pocchiari M., Hofman A. and Smith P. G. (1996) A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347, 921925.
  • Williams E. S. and Young S. (1980) Chronic wasting disease of captive mule deer: a spongiform encephalopathy. J. Wildl. Dis. 16, 8998.
  • Zanusso G., Ferrari S., Cardone F. et al. (2003) Detection of pathologic prion protein in the olfactory epithelium in sporadic Creutzfeldt-Jakob disease. N. Engl. J. Med. 348, 711719.
  • Zeidler M., Stewart G., Cousens S. N., Estibeiro K. and Will R. G. (1997) Codon 129 genotype and new variant CJD[letter; comment]. Lancet 350, 668.
  • Zeidler M., Sellar R. J., Collie D. A. et al. (2000) The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt-Jakob disease. Lancet 355, 14121418.
  • Zerr I., Pocchiari M., Collins S. et al. (2000) Analysis of EEG and CSF 14–3−3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology 55, 811815.